Telesis Bio Inc
NASDAQ:TBIO
Telesis Bio Inc
NASDAQ:TBIO
Price:
0.055
USD
Market Closed
Market Cap:
$4.3m
Relative Value
There is not enough data to reliably calculate the relative value of TBIO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TBIO
Relative Value
Base Case
Not Available
Multiples Across Competitors
TBIO Competitors Multiples
Telesis Bio Inc Competitors
Telesis Bio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Telesis Bio Inc
NASDAQ:TBIO
|
4.3m USD | 0.3 | -0.1 | -0.2 | -0.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 384.4 | 4 552.1 | 1 443.2 | 3 083.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
204.9B USD | 4.6 | 30.6 | 21.2 | 28.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
153.2B USD | 6.2 | 42.4 | 23.4 | 35.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
46.3T KRW | 8.4 | 29 | 16.9 | 22.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.4B CHF | 5.5 | 37.6 | 27.7 | 27.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280B CNY | 6.3 | 18.7 | 18.8 | 18.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
36.9B USD | 5.3 | 28.3 | 20.6 | 24.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
32B USD | 2 | 25 | 12.7 | 19 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.3B USD | 7.2 | 33.8 | 24.4 | 27.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
22.8B USD | 7.4 | 35.2 | 22.7 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
